Bronchial responsiveness to methacholine and adenosine 5′‐monophosphate in young children with asthma: their relationship with blood eosinophils and serum eosinophil cationic protein
Background: Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood eosinophil numbers and serum levels of eosinophil cationic protein (ECP) are considered as indirect measures of airway inflammatio...
Saved in:
Published in | Allergy Vol. 62; no. 10; pp. 1119 - 1124 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.10.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 0105-4538 1398-9995 0108-1675 |
DOI | 10.1111/j.1398-9995.2007.01412.x |
Cover
Abstract | Background: Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood eosinophil numbers and serum levels of eosinophil cationic protein (ECP) are considered as indirect measures of airway inflammation in asthma. The aim of this study was to investigate whether bronchial responsiveness to adenosine 5′‐monophosphate (AMP) is more closely associated with blood eosinophil markers, compared with that to methacholine, in young children with asthma.
Methods: Methacholine and AMP bronchial challenges were performed in 4‐ to 6‐year‐old children with asthma (n = 77) and in healthy controls (n = 32), using a modified auscultation method. The end‐point was defined as the appearance of wheezing and/or oxygen desaturation. The peripheral blood eosinophil counts and serum ECP concentrations were determined in each subject.
Results: A positive response to methacholine (end‐point concentration ≤8 mg/ml) and to AMP (end‐point concentration ≤200 mg/ml) was observed in 74 (96.1%) and 66 asthmatic children (85.7%), respectively. A majority of controls was unresponsive to both challenges. In the asthma group, there was no significant correlation between methacholine end‐point concentration and the eosinophil counts (r = −0.111, P = 0.337) or serum ECP levels (r = −0.126, P = 0.274). In contrast, AMP end‐point concentration correlated significantly with the eosinophil counts (r = −0.372, P = 0.001) and with serum ECP levels (r = −0.371, P = 0.001).
Conclusions: Our results suggest that bronchial responsiveness to AMP is more closely related to airway inflammation, compared with that to methacholine, and support the potential usefulness of AMP challenges in detecting inflammatory changes in young children with asthma. |
---|---|
AbstractList | Background: Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood eosinophil numbers and serum levels of eosinophil cationic protein (ECP) are considered as indirect measures of airway inflammation in asthma. The aim of this study was to investigate whether bronchial responsiveness to adenosine 5′‐monophosphate (AMP) is more closely associated with blood eosinophil markers, compared with that to methacholine, in young children with asthma.
Methods: Methacholine and AMP bronchial challenges were performed in 4‐ to 6‐year‐old children with asthma (n = 77) and in healthy controls (n = 32), using a modified auscultation method. The end‐point was defined as the appearance of wheezing and/or oxygen desaturation. The peripheral blood eosinophil counts and serum ECP concentrations were determined in each subject.
Results: A positive response to methacholine (end‐point concentration ≤8 mg/ml) and to AMP (end‐point concentration ≤200 mg/ml) was observed in 74 (96.1%) and 66 asthmatic children (85.7%), respectively. A majority of controls was unresponsive to both challenges. In the asthma group, there was no significant correlation between methacholine end‐point concentration and the eosinophil counts (r = −0.111, P = 0.337) or serum ECP levels (r = −0.126, P = 0.274). In contrast, AMP end‐point concentration correlated significantly with the eosinophil counts (r = −0.372, P = 0.001) and with serum ECP levels (r = −0.371, P = 0.001).
Conclusions: Our results suggest that bronchial responsiveness to AMP is more closely related to airway inflammation, compared with that to methacholine, and support the potential usefulness of AMP challenges in detecting inflammatory changes in young children with asthma. Background: Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood eosinophil numbers and serum levels of eosinophil cationic protein (ECP) are considered as indirect measures of airway inflammation in asthma. The aim of this study was to investigate whether bronchial responsiveness to adenosine 5′‐monophosphate (AMP) is more closely associated with blood eosinophil markers, compared with that to methacholine, in young children with asthma. Methods: Methacholine and AMP bronchial challenges were performed in 4‐ to 6‐year‐old children with asthma ( n = 77) and in healthy controls ( n = 32), using a modified auscultation method. The end‐point was defined as the appearance of wheezing and/or oxygen desaturation. The peripheral blood eosinophil counts and serum ECP concentrations were determined in each subject. Results: A positive response to methacholine (end‐point concentration ≤8 mg/ml) and to AMP (end‐point concentration ≤200 mg/ml) was observed in 74 (96.1%) and 66 asthmatic children (85.7%), respectively. A majority of controls was unresponsive to both challenges. In the asthma group, there was no significant correlation between methacholine end‐point concentration and the eosinophil counts ( r = −0.111, P = 0.337) or serum ECP levels ( r = −0.126, P = 0.274). In contrast, AMP end‐point concentration correlated significantly with the eosinophil counts ( r = −0.372, P = 0.001) and with serum ECP levels ( r = −0.371, P = 0.001). Conclusions: Our results suggest that bronchial responsiveness to AMP is more closely related to airway inflammation, compared with that to methacholine, and support the potential usefulness of AMP challenges in detecting inflammatory changes in young children with asthma. Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood eosinophil numbers and serum levels of eosinophil cationic protein (ECP) are considered as indirect measures of airway inflammation in asthma. The aim of this study was to investigate whether bronchial responsiveness to adenosine 5'-monophosphate (AMP) is more closely associated with blood eosinophil markers, compared with that to methacholine, in young children with asthma.BACKGROUNDBronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood eosinophil numbers and serum levels of eosinophil cationic protein (ECP) are considered as indirect measures of airway inflammation in asthma. The aim of this study was to investigate whether bronchial responsiveness to adenosine 5'-monophosphate (AMP) is more closely associated with blood eosinophil markers, compared with that to methacholine, in young children with asthma.Methacholine and AMP bronchial challenges were performed in 4- to 6-year-old children with asthma (n = 77) and in healthy controls (n = 32), using a modified auscultation method. The end-point was defined as the appearance of wheezing and/or oxygen desaturation. The peripheral blood eosinophil counts and serum ECP concentrations were determined in each subject.METHODSMethacholine and AMP bronchial challenges were performed in 4- to 6-year-old children with asthma (n = 77) and in healthy controls (n = 32), using a modified auscultation method. The end-point was defined as the appearance of wheezing and/or oxygen desaturation. The peripheral blood eosinophil counts and serum ECP concentrations were determined in each subject.A positive response to methacholine (end-point concentration < or =8mg/ml) and to AMP (end-point concentration < or =200 mg/ml) was observed in 74 (96.1%) and 66 asthmatic children (85.7%), respectively. A majority of controls was unresponsive to both challenges. In the asthma group, there was no significant correlation between methacholine end-point concentration and the eosinophil counts (r = -0.111, P = 0.337) or serum ECP levels (r = -0.126, P = 0.274). In contrast, AMP end-point concentration correlated significantly with the eosinophil counts (r = -0.372, P = 0.001) and with serum ECP levels (r = -0.371, P = 0.001).RESULTSA positive response to methacholine (end-point concentration < or =8mg/ml) and to AMP (end-point concentration < or =200 mg/ml) was observed in 74 (96.1%) and 66 asthmatic children (85.7%), respectively. A majority of controls was unresponsive to both challenges. In the asthma group, there was no significant correlation between methacholine end-point concentration and the eosinophil counts (r = -0.111, P = 0.337) or serum ECP levels (r = -0.126, P = 0.274). In contrast, AMP end-point concentration correlated significantly with the eosinophil counts (r = -0.372, P = 0.001) and with serum ECP levels (r = -0.371, P = 0.001).Our results suggest that bronchial responsiveness to AMP is more closely related to airway inflammation, compared with that to methacholine, and support the potential usefulness of AMP challenges in detecting inflammatory changes in young children with asthma.CONCLUSIONSOur results suggest that bronchial responsiveness to AMP is more closely related to airway inflammation, compared with that to methacholine, and support the potential usefulness of AMP challenges in detecting inflammatory changes in young children with asthma. Background: Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood eosinophil numbers and serum levels of eosinophil cationic protein (ECP) are considered as indirect measures of airway inflammation in asthma. The aim of this study was to investigate whether bronchial responsiveness to adenosine 5'-monophosphate (AMP) is more closely associated with blood eosinophil markers, compared with that to methacholine, in young children with asthma. Methods: Methacholine and AMP bronchial challenges were performed in 4- to 6-year-old children with asthma (n = 77) and in healthy controls (n = 32), using a modified auscultation method. The end-point was defined as the appearance of wheezing and-or oxygen desaturation. The peripheral blood eosinophil counts and serum ECP concentrations were determined in each subject. Results: A positive response to methacholine (end-point concentration less than or equal to 8 mg-ml) and to AMP (end-point concentration less than or equal to 200 mg-ml) was observed in 74 (96.1%) and 66 asthmatic children (85.7%), respectively. A majority of controls was unresponsive to both challenges. In the asthma group, there was no significant correlation between methacholine end-point concentration and the eosinophil counts (r = -0.111, P = 0.337) or serum ECP levels (r = -0.126, P = 0.274). In contrast, AMP end-point concentration correlated significantly with the eosinophil counts (r = -0.372, P = 0.001) and with serum ECP levels (r = -0.371, P = 0.001). Conclusions: Our results suggest that bronchial responsiveness to AMP is more closely related to airway inflammation, compared with that to methacholine, and support the potential usefulness of AMP challenges in detecting inflammatory changes in young children with asthma. Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood eosinophil numbers and serum levels of eosinophil cationic protein (ECP) are considered as indirect measures of airway inflammation in asthma. The aim of this study was to investigate whether bronchial responsiveness to adenosine 5'-monophosphate (AMP) is more closely associated with blood eosinophil markers, compared with that to methacholine, in young children with asthma. Methacholine and AMP bronchial challenges were performed in 4- to 6-year-old children with asthma (n = 77) and in healthy controls (n = 32), using a modified auscultation method. The end-point was defined as the appearance of wheezing and/or oxygen desaturation. The peripheral blood eosinophil counts and serum ECP concentrations were determined in each subject. A positive response to methacholine (end-point concentration < or =8mg/ml) and to AMP (end-point concentration < or =200 mg/ml) was observed in 74 (96.1%) and 66 asthmatic children (85.7%), respectively. A majority of controls was unresponsive to both challenges. In the asthma group, there was no significant correlation between methacholine end-point concentration and the eosinophil counts (r = -0.111, P = 0.337) or serum ECP levels (r = -0.126, P = 0.274). In contrast, AMP end-point concentration correlated significantly with the eosinophil counts (r = -0.372, P = 0.001) and with serum ECP levels (r = -0.371, P = 0.001). Our results suggest that bronchial responsiveness to AMP is more closely related to airway inflammation, compared with that to methacholine, and support the potential usefulness of AMP challenges in detecting inflammatory changes in young children with asthma. Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood eosinophil numbers and serum levels of eosinophil cationic protein (ECP) are considered as indirect measures of airway inflammation in asthma. The aim of this study was to investigate whether bronchial responsiveness to adenosine 5'-monophosphate (AMP) is more closely associated with blood eosinophil markers, compared with that to methacholine, in young children with asthma. Methacholine and AMP bronchial challenges were performed in 4- to 6-year-old children with asthma (n = 77) and in healthy controls (n = 32), using a modified auscultation method. The end-point was defined as the appearance of wheezing and/or oxygen desaturation. The peripheral blood eosinophil counts and serum ECP concentrations were determined in each subject. A positive response to methacholine (end-point concentration Our results suggest that bronchial responsiveness to AMP is more closely related to airway inflammation, compared with that to methacholine, and support the potential usefulness of AMP challenges in detecting inflammatory changes in young children with asthma. |
Author | Kim, D. K. Yu, J. Koh, Y. Y. Choi, S. H. Yoo, Y. |
Author_xml | – sequence: 1 givenname: S. H. surname: Choi fullname: Choi, S. H. – sequence: 2 givenname: D. K. surname: Kim fullname: Kim, D. K. – sequence: 3 givenname: J. surname: Yu fullname: Yu, J. – sequence: 4 givenname: Y. surname: Yoo fullname: Yoo, Y. – sequence: 5 givenname: Y. Y. surname: Koh fullname: Koh, Y. Y. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17573858$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkk1u1DAcxS1URKeFKyCv2E2wHTuxkUAqFV_SSGxgbTnJf4hHjh1sT9vZ9QichSXH6UlIZkqF2Aze-Ou935Psd4ZOfPCAEKakoNN4uSloqeRSKSUKRkhdEMopK24eocXDxQlaEErEkotSnqKzlDZkUjJFnqBTWou6lEIu0K-3Mfi2t8bhCGkMPtkr8JASzgEPkHvT9sFZD9j4DpsOfEjzTtzd_ry7_TEEH8Y-pLE3GbD1eBe2_huegK6L4PG1zT02KfeDeYVzDzZOMc5kOwX1djzcNy6EDsMMnmDWpX1Wgrgd_jrF7d5mWzzGkMH6p-jx2rgEz-7nc_T1_bsvlx-Xq88fPl1erJYtrxVbgmqlqPi6Yg3w0jSqkUoYwRraNJVhVc3ZuhOV4ZJWomUUyopSIkvDjFGcm_IcvThwp9zvW0hZDza14JzxELZJV5KJSkh6VMhrXrKSq6NCRgThXM3E5_fCbTNAp8doBxN3-s__TYI3B0EbQ0oR1rq1ef9OORrrNCV6Loze6LkXeu6Fnguj94XRNxNA_gN4yDhufX2wXlsHu__26YvVal6VvwGUH96r |
CitedBy_id | crossref_primary_10_1016_S1081_1206_10_60353_5 crossref_primary_10_1097_MCP_0b013e32831fb1f3 crossref_primary_10_1002_ppul_25614 crossref_primary_10_1016_j_prrv_2017_06_010 crossref_primary_10_1186_s13223_020_0410_x crossref_primary_10_1111_cea_12539 crossref_primary_10_1164_rccm_201704_0715LE crossref_primary_10_2500_ajra_2011_25_3685 crossref_primary_10_4168_aair_2012_4_6_341 crossref_primary_10_1183_13993003_01033_2018 crossref_primary_10_1371_journal_pone_0037560 crossref_primary_10_1016_j_anai_2009_11_012 crossref_primary_10_1111_cea_12445 crossref_primary_10_3109_02770903_2011_565850 crossref_primary_10_1016_j_jpeds_2012_03_033 crossref_primary_10_1097_MCP_0b013e3282f197f6 crossref_primary_10_1016_j_rmed_2010_04_014 crossref_primary_10_1007_s11882_009_0036_z crossref_primary_10_1016_j_jaip_2021_07_021 crossref_primary_10_1089_pai_2007_9993 crossref_primary_10_3109_02770903_2012_692845 crossref_primary_10_1089_ped_2019_1028 |
Cites_doi | 10.1111/j.1365-2222.1995.tb00024.x 10.1016/S0954-6111(05)80010-1 10.1002/ppul.20249 10.1164/ajrccm.164.7.2102135 10.1046/j.1365-2222.2002.01546.x 10.1164/ajrccm.162.3.9910037 10.1164/ajrccm.162.4.9912103 10.1164/ajrccm.153.3.8630572 10.5694/j.1326-5377.1997.tb138856.x 10.1016/S1526-0542(04)90018-8 10.1111/j.1398-9995.2004.00504.x 10.1136/thx.51.6.582 10.1097/00130832-200302000-00011 10.1046/j.1365-2222.1998.00217.x 10.1056/NEJM199010113231505 10.1111/j.1365-2222.2005.02177.x 10.1046/j.1365-2222.1999.00542.x 10.1164/ajrccm.162.4.9912111 10.1002/ppul.1124 10.1042/cs0730561 10.1164/ajrccm.157.1.9703002 10.1164/ajrccm.163.7.2010145 10.1002/(SICI)1099-0496(199801)25:1<1::AID-PPUL1>3.0.CO;2-S 10.1183/09031936.99.14511759 10.1111/j.1365-2222.1993.tb00372.x 10.1111/j.1365-2222.2004.01830.x 10.1002/ppul.20402 10.1111/j.1365-2222.1996.tb00627.x 10.1164/ajrccm.165.3.2104066 10.1002/1099-0496(200009)30:3<207::AID-PPUL5>3.0.CO;2-Z 10.1016/0091-6749(85)90795-X 10.1034/j.1398-9995.2000.00312.x |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7S9 L.6 7X8 |
DOI | 10.1111/j.1398-9995.2007.01412.x |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1398-9995 0108-1675 |
EndPage | 1124 |
ExternalDocumentID | 17573858 10_1111_j_1398_9995_2007_01412_x ALL1412 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAHHS AAYXX ACCFJ AEEZP AEQDE AIWBW AJBDE CITATION 24P AEUQT AFPWT CGR CUY CVF DIK ECM EIF ESX NPM WRC WUP 7T5 H94 7S9 L.6 7X8 |
ID | FETCH-LOGICAL-c4792-e9c8564f62be43ab9b895a52b1bb6a26742fd56a48165c21e3611083a2aa944a3 |
IEDL.DBID | DR2 |
ISSN | 0105-4538 |
IngestDate | Fri Jul 11 06:37:12 EDT 2025 Fri Jul 11 10:40:05 EDT 2025 Fri Jul 11 03:03:00 EDT 2025 Wed Feb 19 02:12:29 EST 2025 Thu Apr 24 23:02:39 EDT 2025 Tue Jul 01 04:14:39 EDT 2025 Wed Aug 20 07:26:58 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4792-e9c8564f62be43ab9b895a52b1bb6a26742fd56a48165c21e3611083a2aa944a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1398-9995.2007.01412.x |
PMID | 17573858 |
PQID | 20504491 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_68256581 proquest_miscellaneous_47432349 proquest_miscellaneous_20504491 pubmed_primary_17573858 crossref_citationtrail_10_1111_j_1398_9995_2007_01412_x crossref_primary_10_1111_j_1398_9995_2007_01412_x wiley_primary_10_1111_j_1398_9995_2007_01412_x_ALL1412 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2007 2007-10-00 2007-Oct 20071001 |
PublicationDateYYYYMMDD | 2007-10-01 |
PublicationDate_xml | – month: 10 year: 2007 text: October 2007 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Denmark |
PublicationTitle | Allergy |
PublicationTitleAlternate | Allergy |
PublicationYear | 2007 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 1995; 74 1998; 28 1993; 23 1990; 323 2001; 164 1987; 73 2001; 163 1999; 29 2002; 32 2005; 40 1994; 88 1996; 51 2004; 5 1998; 157 1998; 25 2006; 41 2002; 165 1995; 25 2004; 59 2000; 55 2004; 34 2000; 30 1997; 167 1999; 14 2003; 3 2000; 162 1996; 153 1985; 76 1996; 26 2005; 35 2001; 32 e_1_2_6_31_2 e_1_2_6_30_2 e_1_2_6_18_2 e_1_2_6_19_2 e_1_2_6_12_2 e_1_2_6_35_2 e_1_2_6_13_2 e_1_2_6_34_2 e_1_2_6_10_2 e_1_2_6_33_2 e_1_2_6_11_2 e_1_2_6_32_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 Warner JO (e_1_2_6_22_2) 1998; 25 Smith L (e_1_2_6_2_2) 1995; 74 e_1_2_6_20_2 e_1_2_6_8_2 e_1_2_6_7_2 Roquet A (e_1_2_6_29_2) 1996; 51 e_1_2_6_9_2 e_1_2_6_4_2 e_1_2_6_3_2 e_1_2_6_6_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_21_2 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 e_1_2_6_25_2 |
References_xml | – volume: 76 start-page: 1 year: 1985 end-page: 15 article-title: Continuing medical education. Asthma in infants and children: Part 1 publication-title: J Allergy Clin Immunol – volume: 3 start-page: 65 year: 2003 end-page: 69 article-title: The role of adenosine as a novel bronchoprovocant in asthma publication-title: Curr Opin Allergy Clin Immunol – volume: 165 start-page: 327 year: 2002 end-page: 331 article-title: Bronchial responsiveness to adenosine 5′‐monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV publication-title: Am J Respir Crit Care Med – volume: 163 start-page: 1546 year: 2001 end-page: 1550 article-title: PC adenosine 5′‐monophosphate is more closely associated with airway inflammation in asthma than PC methacholine publication-title: Am J Respir Crit Care Med – volume: 162 start-page: 1318 year: 2000 end-page: 1322 article-title: Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)‐receptor genotype publication-title: Am J Respir Crit Care Med – volume: 73 start-page: 561 year: 1987 end-page: 572 article-title: The pathogenesis and significance of bronchial hyper‐responsiveness in airways disease publication-title: Clin Sci – volume: 164 start-page: 1127 year: 2001 end-page: 1132 article-title: Corticosteroid‐induced improvement in the PC of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC of methacholine publication-title: Am J Respir Crit Care Med – volume: 25 start-page: 1 year: 1998 end-page: 17 article-title: Third International Pediatric Consensus statement on the management of childhood asthma International Pediatric Asthma Consensus Group publication-title: Pediatr Pulmonol – volume: 153 start-page: 910 year: 1996 end-page: 917 article-title: Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma publication-title: Am J Respir Crit Care Med – volume: 28 start-page: 233 year: 1998 end-page: 240 article-title: Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma publication-title: Clin Exp Allergy – volume: 51 start-page: 482 year: 1996 end-page: 488 article-title: Eosinophil activity markers in peripheral blood have high predictive value for bronchial hyperreactivity in patients with suspected mild asthma publication-title: Allergy – volume: 59 start-page: 839 year: 2004 end-page: 844 article-title: Induced sputum in children with newly diagnosed mild asthma: the effect of 6 months of treatment with budesonide or disodium cromoglycate publication-title: Allergy – volume: 41 start-page: 538 year: 2006 end-page: 543 article-title: Bronchial responsiveness to methacholine and adenosine 5′‐monophosphate in preschool children with bronchopulmonary dysplasia publication-title: Pediatr Pulmonol – volume: 55 start-page: 355 year: 2000 end-page: 362 article-title: Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing publication-title: Allergy – volume: 23 start-page: 3 issue: Suppl. 2 year: 1993 end-page: 7 article-title: Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma publication-title: Clin Exp Allergy – volume: 162 start-page: 1403 year: 2000 end-page: 1406 article-title: A clinical index to define risk of asthma in young children with recurrent wheezing publication-title: Am J Respir Crit Care Med – volume: 14 start-page: 1175 year: 1999 end-page: 1178 article-title: Methacholine challenge in preschool children: methacholine‐induced wheeze versus transcutaneous oximetry publication-title: Eur Respir J – volume: 74 start-page: 454 year: 1995 end-page: 470 article-title: Bronchial hyperreactivity revisited publication-title: Ann Allergy Asthma Immunol – volume: 26 start-page: 918 year: 1996 end-page: 925 article-title: Comparison of basophil histamine release, eosinophil cationic protein and non‐specific airway responsiveness between mite‐sensitive asthmatic and non‐asthmatic children and non‐allergic controls publication-title: Clin Exp Allergy – volume: 88 start-page: 613 year: 1994 end-page: 621 article-title: Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow‐volume curves, PC , and exacerbations publication-title: Respir Med – volume: 29 start-page: 1172 year: 1999 end-page: 1186 article-title: Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease publication-title: Clin Exp Allergy – volume: 323 start-page: 1033 year: 1990 end-page: 1039 article-title: Eosinophilic inflammation in asthma publication-title: N Engl J Med – volume: 35 start-page: 250 year: 2005 end-page: 261 article-title: Indirect bronchial hyper‐responsiveness: the coming of age of a specific group of bronchial challenges publication-title: Clin Exp Allergy – volume: 157 start-page: 4 year: 1998 end-page: 9 article-title: Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma publication-title: Am J Respir Crit Care Med – volume: 162 start-page: 857 year: 2000 end-page: 860 article-title: Efficacy and safety of methacholine bronchial challenge performed by auscultation in young asthmatic children publication-title: Am J Respir Crit Care Med – volume: 5 start-page: S93 issue: Suppl. A year: 2004 end-page: S101 article-title: Phenotype specific treatment of asthma in childhood publication-title: Paediatr Respir Rev – volume: 32 start-page: 308 year: 2001 end-page: 313 article-title: Exhaled nitric oxide and asthma in young children publication-title: Pediatr Pulmonol – volume: 40 start-page: 97 year: 2005 end-page: 104 article-title: Methodological issues related to exhaled nitric oxide measurement in children aged four to six years publication-title: Pediatr Pulmonol – volume: 30 start-page: 207 year: 2000 end-page: 214 article-title: Exercise, methacholine, and adenosine 5′‐monophosphate challenges in children with asthma: relation to severity of the disease publication-title: Pediatr Pulmonol – volume: 51 start-page: 582 year: 1996 end-page: 584 article-title: Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma publication-title: Thorax – volume: 34 start-page: 9 year: 2004 end-page: 16 article-title: Direct or indirect stimuli for bronchial challenge testing: what is the relevance for asthma epidemiology? publication-title: Clin Exp Allergy – volume: 32 start-page: 1728 year: 2002 end-page: 1733 article-title: Concentrations of exhaled nitric oxide in asthmatics and subjects with allergic rhinitis sensitized to the same pollen allergen publication-title: Clin Exp Allergy – volume: 167 start-page: 218 year: 1997 end-page: 223 article-title: Asthma in children publication-title: Med J Aust – volume: 25 start-page: 820 year: 1995 end-page: 827 article-title: Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma publication-title: Clin Exp Allergy – ident: e_1_2_6_6_2 doi: 10.1111/j.1365-2222.1995.tb00024.x – ident: e_1_2_6_28_2 doi: 10.1016/S0954-6111(05)80010-1 – ident: e_1_2_6_35_2 doi: 10.1002/ppul.20249 – ident: e_1_2_6_13_2 doi: 10.1164/ajrccm.164.7.2102135 – ident: e_1_2_6_34_2 doi: 10.1046/j.1365-2222.2002.01546.x – ident: e_1_2_6_18_2 doi: 10.1164/ajrccm.162.3.9910037 – ident: e_1_2_6_24_2 doi: 10.1164/ajrccm.162.4.9912103 – ident: e_1_2_6_32_2 doi: 10.1164/ajrccm.153.3.8630572 – ident: e_1_2_6_16_2 doi: 10.5694/j.1326-5377.1997.tb138856.x – ident: e_1_2_6_33_2 doi: 10.1016/S1526-0542(04)90018-8 – ident: e_1_2_6_9_2 doi: 10.1111/j.1398-9995.2004.00504.x – ident: e_1_2_6_11_2 doi: 10.1136/thx.51.6.582 – ident: e_1_2_6_10_2 doi: 10.1097/00130832-200302000-00011 – ident: e_1_2_6_8_2 doi: 10.1046/j.1365-2222.1998.00217.x – ident: e_1_2_6_5_2 doi: 10.1056/NEJM199010113231505 – ident: e_1_2_6_4_2 doi: 10.1111/j.1365-2222.2005.02177.x – ident: e_1_2_6_7_2 doi: 10.1046/j.1365-2222.1999.00542.x – ident: e_1_2_6_17_2 doi: 10.1164/ajrccm.162.4.9912111 – ident: e_1_2_6_20_2 doi: 10.1002/ppul.1124 – ident: e_1_2_6_25_2 doi: 10.1042/cs0730561 – ident: e_1_2_6_30_2 doi: 10.1164/ajrccm.157.1.9703002 – ident: e_1_2_6_12_2 doi: 10.1164/ajrccm.163.7.2010145 – volume: 25 start-page: 1 year: 1998 ident: e_1_2_6_22_2 article-title: Third International Pediatric Consensus statement on the management of childhood asthma International Pediatric Asthma Consensus Group publication-title: Pediatr Pulmonol doi: 10.1002/(SICI)1099-0496(199801)25:1<1::AID-PPUL1>3.0.CO;2-S – ident: e_1_2_6_23_2 doi: 10.1183/09031936.99.14511759 – ident: e_1_2_6_19_2 doi: 10.1111/j.1365-2222.1993.tb00372.x – volume: 51 start-page: 482 year: 1996 ident: e_1_2_6_29_2 article-title: Eosinophil activity markers in peripheral blood have high predictive value for bronchial hyperreactivity in patients with suspected mild asthma publication-title: Allergy – volume: 74 start-page: 454 year: 1995 ident: e_1_2_6_2_2 article-title: Bronchial hyperreactivity revisited publication-title: Ann Allergy Asthma Immunol – ident: e_1_2_6_3_2 doi: 10.1111/j.1365-2222.2004.01830.x – ident: e_1_2_6_15_2 doi: 10.1002/ppul.20402 – ident: e_1_2_6_27_2 doi: 10.1111/j.1365-2222.1996.tb00627.x – ident: e_1_2_6_14_2 doi: 10.1164/ajrccm.165.3.2104066 – ident: e_1_2_6_31_2 doi: 10.1002/1099-0496(200009)30:3<207::AID-PPUL5>3.0.CO;2-Z – ident: e_1_2_6_21_2 doi: 10.1016/0091-6749(85)90795-X – ident: e_1_2_6_26_2 doi: 10.1034/j.1398-9995.2000.00312.x |
SSID | ssj0007290 ssj0012798 ssj0068258 |
Score | 2.0047743 |
Snippet | Background: Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect... Background: Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect... Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect stimuli. Blood... Background: Bronchial hyperresponsiveness is a characteristic feature of asthma, and is usually measured by bronchial challenges using direct or indirect... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1119 |
SubjectTerms | adenosine 5′‐monophosphate Adenosine Monophosphate Adenosine Monophosphate - immunology asthma Asthma - diagnosis Asthma - immunology blood Bronchial Hyperreactivity Bronchial Hyperreactivity - diagnosis Bronchial Hyperreactivity - immunology Bronchial Provocation Tests Bronchitis Bronchitis - diagnosis Bronchitis - immunology Child Child, Preschool diagnosis diagnostic use enzymology Eosinophil Cationic Protein Eosinophil Cationic Protein - blood Eosinophil Cationic Protein - immunology eosinophils Eosinophils - enzymology Eosinophils - immunology Female Humans Hypersensitivity, Immediate Hypersensitivity, Immediate - blood Hypersensitivity, Immediate - immunology immunology Male methacholine Methacholine Chloride Methacholine Chloride - immunology |
Title | Bronchial responsiveness to methacholine and adenosine 5′‐monophosphate in young children with asthma: their relationship with blood eosinophils and serum eosinophil cationic protein |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1398-9995.2007.01412.x https://www.ncbi.nlm.nih.gov/pubmed/17573858 https://www.proquest.com/docview/20504491 https://www.proquest.com/docview/47432349 https://www.proquest.com/docview/68256581 |
Volume | 62 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLVQF4gN78fw9IJtRvgZm10FVBVqWSAqdRfZjqOJOk1GMxmpsOon8C0s-Zx-Cfc6SdsBKlWI3Txsx5HvsY-vr88l5LXUQQnnTOZ4iJn0VmRelCFDLaoSFtyQV-jQ3_-kdw_kx0N1OMQ_4V2YXh_i3OGGyEjzNQLc-dUmyIUFsFqrBiVCJhmfIp9kQqOM_vvPF0pS-eBuATqRSQD5ZlDPXxvaXKn-oJ-bbDYtRzt3yNH4In0UytF03flp-PabxuP_edO75PbAWul2b2b3yI3Y3Cc394dz-QfkJ-zmG4yantPlEHTbT6K0aykmqcacLNgR6pqSuhIVyvGbOjv9cXb6HaDQLmbtajED5kvrhn7FOYiOF80pOoupW3WzY_eWpqMNuhyD-Gb1ov8_heDTiA1DY_V8lZ4FCFsfX_qV9i7KOtCkUFE3D8nBzocv73azIStEFmRueRZtMErLSnMfpXDeemOVU9wz77XjGvb6Vam0k4ZpFTiLQuNVB-G4c1ZKJx6RraZt4hNCSxZLD_zSiAgbxao0RvLSMNQYZF5V1YTkowUUYZBMx8wd8-LS1gmGpsChwYSeeZGGpjiZEHZec9HLhlyjzqvRyArAOB7cuCa26xWUUm-ktOzqEhKIIBfSXl1CGyC3ykAbj3v7vehXrpKk0YToZIXX7nCxvbeHn57-a8Vn5FZylafYyOdkq1uu4wvgeJ1_mdD7C9MOSGk |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQkYAL78fyqg9cs8LP2NwqoFpgtwfUSr1FduJoo26T1T4k4NSfwG_hyM_pL2HGSdouUKlC3PKwHUeesb8Zj78h5JXUuRLOmcTxPCTSW5F4UeQJclEVsODmaYkO_cmeHh3Ij4fqsEsHhGdhWn6IM4cbakacr1HB0SG9qeXCgrZaqzoqQiYZHwKgvC4Bd6Al9u7zOZdU2jlcAFAkEtR8M6znry1trlV_ANBNPBsXpN07ZNb_ShuHcjRcr_ww__Yby-N_-te75HYHXOlOK2n3yLVQ3yc3Jt3W_APyEwz6GgOnZ3TRxd228yhdNRTzVGNaFuwJdXVBXYEk5XinTk9-nJ58B21o5tNmOZ8C-KVVTb_iNET7s-YU_cXULVfTY_eGxt0Nuujj-KbVvH0fo_BpwIahsWq2jN8CJVsfX3hKWy9lldNIUlHVD8nB7vv9t6OkSwyR5DK1PAk2N0rLUnMfpHDeemOVU9wz77XjGsz9slDaScO0yjkLQuNpB-G4c1ZKJx6RrbqpwxNCCxYKDxDTiAC2YlkYI3lhGNIMMq_KckDSXgSyvGNNx-Qds-yC9QRDk-HQYE7PNItDk30ZEHZWc94yh1yhznYvZRmoOe7duDo06yWUUq-ltOzyEhKwIBfSXl5CG8C3ykAbj1sBPu9XqiKr0YDoKIZX7nC2Mx7j1dN_rbhNbo72J-Ns_GHv0zNyK3rOY6jkc7K1WqzDC4B8K_8yqvIvRktMiA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQkSouQPldoNQHrlnhxHZsbhWwKrCtEKJSb5HtONqo2yTazUrAqY_As3DkcfokzDhJ2wUqVYjb_tiOI89nfx6PvyHkBZdOJMaoyMTOR9zqJLJJ7iLUosphwXVpgQ79_QO5d8jfH4mjPv4J78J0-hDnDjdERpivEeBNXqyDPNEAVq1Fr0TIOIvHwCdvcgnEAgnSpwspqbT3twCfiDigfD2q568trS9Vf_DPdTob1qPJHXI8vEkXhnI8XrV27L79JvL4f171Lrnd01a629nZFrnhq3tkc78_mL9PfsJ2vsKw6Tld9FG33SxK25pilmpMyoIdoabKqclRohy_ibPTH2en3wELdTOrl80MqC8tK_oVJyE63DSn6C2mZtnOTswrGs426GKI4puVTfd_iMGnHhuGxsr5MjwLILY6ufQr7XyUpaNBoqKsHpDDydvPr_eiPi1E5Hiq48hrp4TkhYyt54mx2iotjIgts1aaWMJmv8iFNFwxKVzMfCLxrkNiYmM05yZ5SDaquvKPCc2Zzy0QTJV42CkWuVI8zhVDkUFmRVGMSDpYQOZ6zXRM3THPLu2dYGgyHBrM6JlmYWiyLyPCzms2nW7INersDEaWAcjx5MZUvl4toZR4yblmV5fgwATjhOurS0gF7FYoaONRZ78X_UpF0DQaERms8NodznanU_z05F8r7pDNj28m2fTdwYen5FZwm4c4yWdko12s_DbwvdY-D0D-BR9SSzc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bronchial+responsiveness+to+methacholine+and+adenosine+5%27-monophosphate+in+young+children+with+asthma%3A+their+relationship+with+blood+eosinophils+and+serum+eosinophil+cationic+protein&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Choi%2C+S+H&rft.au=Kim%2C+D+K&rft.au=Yu%2C+J&rft.au=Yoo%2C+Y&rft.date=2007-10-01&rft.issn=0105-4538&rft.volume=62&rft.issue=10&rft.spage=1119&rft_id=info:doi/10.1111%2Fj.1398-9995.2007.01412.x&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |